Proactive Investors - Run By Investors For Investors

Aphria rebuffs Green Growth Brand's hostile takeover bid

The potential takeover would have had 'negative repercussions, including delisting from the TSX and NYSE and a potential reduction in interest from strategic partners,' according to Aphria
merger metaphor
Aphria's board called US rival Green Growth a company with 'limited' operations

Aphria Inc shares (NYSE:APHA) slid Wednesday after the Canadian cannabis producer rebuffed US rival Green Growth Brands Inc’s hostile takeover bid on the view that it “significantly undervalued” the company and is “inadequate”.

Green Growth first put an offer to buy Aphria on the table in December, which was also rejected, and then last month, introduced a second nearly identical unsolicited bid for Aphria, which put its value at roughly C$2.35 billion (US:$1.76 bn).

READ: Green Growth Brands pursues Aphria with second hostile bid

On Wednesday, Aphria issued a statement saying its board had moved to reject the hostile bid, arguing that it would have given Green Growth shareholders a 36% interest in Aphria in exchange for shares in a company with "limited" operations.

“The Aphria Board of Directors unanimously believes that GGB’s hostile offer is significantly undervalued and inadequate and not in the interest of Aphria shareholders on multiple grounds,” said Irwin Simon, Aphria’s board chairman in a statement.

The potential takeover would also have had “negative repercussions, including delisting from the TSX and NYSE and a potential reduction in interest from strategic partners,” according to the statement.

Aphria’s shares took a hit last December in the wake of the release of a critical report from short sellers Quintessential Capital Management and Hindenburg Research, which cast doubt on the company’s dealings in Latin America. In response to the criticism, Aphria’s board appointed a special committee to investigate the short-sellers’ allegations.

News of Aphria’s rejection of Green Growth’s bid also comes at a time of uncertainty for Aphria’s management. Last month, Aphria’ said its CEO and co-founder Vic Neufeld will step down from the company’s helm.

Investors failed to applaud the news, sending Aphria shares down 6.16% to $10.05 before the opening bell on Wednesday.

Contact Ellen Kelleher at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full APHA profile View Profile

Aphria Timeline

Related Articles

Cannabis leaf
November 19 2018
With the legalisation of recreational cannabis in Canada in October, and the US expected to follow suit, the company has its sights set on building up the very best in the industry
A visual representation of a drug candidate working in a dog
January 28 2019
The company has reaffirmed its upcoming milestones as it confirmed December quarter achievements.
Empower clinic locations
March 26 2019
Empower Clinics is one of the largest operators of medical-cannabis-focused healthcare in the US
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use